Literature DB >> 18058020

Dietary fiber is associated with serum sex hormones and insulin-related peptides in postmenopausal breast cancer survivors.

Sharon J Wayne1, Marian L Neuhouser, Cornelia M Ulrich, Carol Koprowski, Kathy B Baumgartner, Richard N Baumgartner, Anne McTiernan, Leslie Bernstein, Rachel Ballard-Barbash.   

Abstract

OBJECTIVE: To measure the association between dietary fiber intake and eleven hormones and peptides in postmenopausal breast cancer survivors.
METHODS: Intake of fiber from food and supplements was measured two to three years after breast cancer diagnosis in 493 postmenopausal women from three western states. Concurrently, a fasting blood sample was obtained for assay of estrone, estradiol, free estradiol, testosterone, free testosterone, dehydroepiandrosterone sulfate, sex hormone-binding globulin (SHBG), leptin, C-peptide, insulin-like growth factor-1 (IGF1), and IGF-binding protein-3. Adjusted means of these hormones and peptides were calculated for categories of fiber intake.
RESULTS: High intake of dietary fiber was significantly (P<or=0.05) associated with low serum levels of estradiol and free estradiol and with high serum levels of IGF1. The combination of high dietary fiber intake and use of fiber supplements was additionally associated with low serum levels of C-peptide. The magnitude of the difference in hormone/peptide values, comparing high fiber intake to low fiber intake, varied from 16 to 28%, and the associations were independent of multiple confounding variables.
CONCLUSION: High fiber diets may be beneficial to postmenopausal breast cancer survivors due to fiber's favorable influence on sex hormones and peptides known to affect breast cancer prognosis.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 18058020     DOI: 10.1007/s10549-007-9834-y

Source DB:  PubMed          Journal:  Breast Cancer Res Treat        ISSN: 0167-6806            Impact factor:   4.872


  6 in total

1.  Fatigue, inflammation, and ω-3 and ω-6 fatty acid intake among breast cancer survivors.

Authors:  Catherine M Alfano; Ikuyo Imayama; Marian L Neuhouser; Janice K Kiecolt-Glaser; Ashley Wilder Smith; Kathleen Meeske; Anne McTiernan; Leslie Bernstein; Kathy B Baumgartner; Cornelia M Ulrich; Rachel Ballard-Barbash
Journal:  J Clin Oncol       Date:  2012-03-12       Impact factor: 44.544

2.  Association between alcohol intake and serum sex hormones and peptides differs by tamoxifen use in breast cancer survivors.

Authors:  Sharon Wayne; Marian L Neuhouser; Cornelia M Ulrich; Carol Koprowski; Charles Wiggins; Kathy B Baumgartner; Leslie Bernstein; Richard N Baumgartner; Frank Gilliland; Anne McTiernan; Rachel Ballard-Barbash
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2008-10-28       Impact factor: 4.254

3.  Breast cancer survivors who use estrogenic botanical supplements have lower serum estrogen levels than non users.

Authors:  Sharon J Wayne; Marian L Neuhouser; Carol Koprowski; Cornelia M Ulrich; Charles Wiggins; Frank Gilliland; Kathy B Baumgartner; Richard N Baumgartner; Anne McTiernan; Leslie Bernstein; Rachel Ballard-Barbash
Journal:  Breast Cancer Res Treat       Date:  2008-10-18       Impact factor: 4.872

4.  Dietary Fiber Intake and Femoral Bone Mineral Density in Middle-Aged and Older US Adults: A Cross-Sectional Study of National Health and Nutrition Examination Survey 2013-2014.

Authors:  Yuchen Tang; Jinmin Liu; Xiaohui Zhang; Bin Geng
Journal:  Front Nutr       Date:  2022-03-14

5.  Effects of Gum Arabic ingestion on body mass index and body fat percentage in healthy adult females: two-arm randomized, placebo controlled, double-blind trial.

Authors:  Rasha Babiker; Tarig H Merghani; Khalifa Elmusharaf; Rehab M Badi; Florian Lang; Amal M Saeed
Journal:  Nutr J       Date:  2012-12-15       Impact factor: 3.271

6.  Design of the SHAPE-2 study: the effect of physical activity, in addition to weight loss, on biomarkers of postmenopausal breast cancer risk.

Authors:  Willemijn A M van Gemert; Jolein I Iestra; Albertine J Schuit; Anne M May; Tim Takken; Wouter B Veldhuis; Job van der Palen; Harriët Wittink; Petra H M Peeters; Evelyn M Monninkhof
Journal:  BMC Cancer       Date:  2013-08-23       Impact factor: 4.430

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.